Holen Sie sich die Stockscreener-App
186.58
1.76%
-3.35
Vorhandelsmarkt:
186.57
-0.01
-0.01%
Schlusskurs vom Vortag:
$189.93
Offen:
$188.44
24-Stunden-Volumen:
700.27K
Relative Volume:
0.72
Marktkapitalisierung:
$14.25B
Einnahmen:
$8.19B
Nettoeinkommen (Verlust:
$758.19M
KGV:
20.32
EPS:
9.18
Netto-Cashflow:
$1.06B
1W Leistung:
+0.38%
1M Leistung:
+14.17%
6M Leistung:
+26.85%
1J Leistung:
-11.49%
1-Tages-Spanne:
$185.81
$191.85
1-Wochen-Bereich:
$178.80
$191.85
52-Wochen-Spanne:
$125.10
$228.28
Icon Plc Stock (ICLR) Company Profile
Firmenname
Icon Plc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie ICLR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
186.58 | 14.50B | 8.19B | 758.19M | 1.06B | 9.18 |
|
TMO
Thermo Fisher Scientific Inc
|
572.28 | 217.50B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.33 | 164.13B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
704.20 | 56.49B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
139.68 | 40.44B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.26 | 38.48B | 15.90B | 1.28B | 2.21B | 7.2842 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-09-09 | Herabstufung | Jefferies | Buy → Hold |
| 2025-09-03 | Hochstufung | Rothschild & Co Redburn | Neutral → Buy |
| 2025-08-21 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-07-24 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-04-29 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-04-14 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-04-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-03-21 | Herabstufung | Goldman | Buy → Neutral |
| 2025-01-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-10-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Neutral |
| 2024-09-18 | Eingeleitet | Leerink Partners | Outperform |
| 2024-06-06 | Eingeleitet | Goldman | Buy |
| 2023-12-15 | Eingeleitet | Truist | Buy |
| 2023-09-13 | Eingeleitet | TD Cowen | Outperform |
| 2023-01-17 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-01-13 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-11-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-09-07 | Eingeleitet | UBS | Buy |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-05-24 | Eingeleitet | Guggenheim | Buy |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-09-27 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-23 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-07-14 | Eingeleitet | Citigroup | Neutral |
| 2021-04-13 | Fortgesetzt | BofA Securities | Neutral |
| 2021-04-01 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | Eingeleitet | Barclays | Equal Weight |
| 2021-03-01 | Hochstufung | UBS | Neutral → Buy |
| 2021-02-26 | Hochstufung | Truist | Hold → Buy |
| 2020-07-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-04-20 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-03-02 | Eingeleitet | Deutsche Bank | Hold |
| 2020-01-27 | Herabstufung | SunTrust | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | Hochstufung | UBS | Sell → Neutral |
| 2019-01-25 | Hochstufung | Mizuho | Neutral → Buy |
| 2018-10-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2018-10-09 | Eingeleitet | UBS | Sell |
| 2018-04-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2018-02-15 | Bestätigt | Mizuho | Neutral |
| 2018-01-19 | Eingeleitet | Evercore ISI | Outperform |
| 2017-10-27 | Bestätigt | Barclays | Equal Weight |
| 2017-09-11 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-31 | Hochstufung | SunTrust | Hold → Buy |
| 2017-07-27 | Bestätigt | Mizuho | Neutral |
| 2017-06-29 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Icon Plc Aktie (ICLR) Neueste Nachrichten
Lazard Asset Management LLC Sells 308,092 Shares of Icon Plc $ICLR - MarketBeat
Neuberger Berman Group LLC Sells 553,413 Shares of Icon Plc $ICLR - MarketBeat
193,000 Shares in Icon Plc $ICLR Purchased by Hudson Bay Capital Management LP - MarketBeat
Icon Plc $ICLR Shares Bought by Holocene Advisors LP - MarketBeat
75,000 Shares in Icon Plc $ICLR Bought by Hound Partners LLC - MarketBeat
Hudson Bay Capital Management LP Makes New $28.07 Million Investment in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Bought by The Manufacturers Life Insurance Company - MarketBeat
Bamco Inc. NY Lowers Position in Icon Plc $ICLR - MarketBeat
Boone Capital Management LLC Invests $13.94 Million in Icon Plc $ICLR - MarketBeat
Sei Investments Co. Acquires 309,635 Shares of Icon Plc $ICLR - MarketBeat
300,000 Shares in Icon Plc $ICLR Purchased by Camber Capital Management LP - MarketBeat
California Public Employees Retirement System Has $22.55 Million Stock Position in Icon Plc $ICLR - MarketBeat
Axa S.A. Cuts Stock Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Bought by Qube Research & Technologies Ltd - MarketBeat
Amundi Sells 7,228 Shares of Icon Plc $ICLR - MarketBeat
ICON plc Releases Findings from Two Biotech Sector Survey - marketscreener.com
Here’s How ICON plc (ICLR) Recovered from Challenges - Insider Monkey
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive - Business Wire
Icon Plc $ICLR Shares Sold by M&T Bank Corp - MarketBeat
Fayez Sarofim & Co Has $13.72 Million Holdings in Icon Plc $ICLR - MarketBeat
Truist Financial Maintains Icon PLC(ICLR.US) With Buy Rating - 富途资讯
Kennedy Capital Management LLC Sells 10,424 Shares of Icon Plc $ICLR - MarketBeat
Brant Point Investment Management LLC Sells 7,000 Shares of Icon Plc $ICLR - MarketBeat
Brown Advisory Inc. Buys 17,717 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Acquired by Jump Financial LLC - MarketBeat
Invesco Ltd. Increases Position in Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Quantbot Technologies LP - MarketBeat
BMO Capital reiterates Market Perform rating on ICON stock with $175 target - Investing.com UK
What ICON (ICLR)'s Trial Site Bottleneck Survey Reveals About Its Evolving CRO Partnership Strategy - simplywall.st
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup - Applied Clinical Trials
14,202 Shares in Icon Plc $ICLR Bought by Taikang Asset Management Hong Kong Co Ltd - MarketBeat
1,090,679 Shares in Icon Plc $ICLR Purchased by Norges Bank - MarketBeat
Distillate Capital Partners LLC Sells 10,245 Shares of Icon Plc $ICLR - MarketBeat
Brandes Investment Partners LP Purchases Shares of 207,533 Icon Plc $ICLR - MarketBeat
1832 Asset Management L.P. Boosts Stock Position in Icon Plc $ICLR - MarketBeat
Iqvia, Icon, Fortrea downgraded at Barclays on tariff overhang - MSN
Free cash flow per share of ICON Plc – TRADEGATE:IJF - TradingView
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Si - PharmiWeb.com
Icon plc Announces Results of Its Latest Industry Survey - marketscreener.com
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions - Business Wire
River Road Asset Management LLC Invests $30.41 Million in Icon Plc $ICLR - MarketBeat
Icon Energy Corp. (ICON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Legacy Capital Wealth Partners LLC Acquires 2,296 Shares of Icon Plc $ICLR - MarketBeat
Russell Investments Group Ltd. Buys 18,198 Shares of Icon Plc $ICLR - MarketBeat
Icon Plc $ICLR Shares Sold by Grandeur Peak Global Advisors LLC - MarketBeat
Cetera Investment Advisers Has $2.03 Million Position in Icon Plc $ICLR - MarketBeat
Icon (ICLR) Net Margin % : 0.12% (As of Sep. 2025) - GuruFocus
Icon (ICLR) Common Stock : $6 Mil (As of Sep. 2025) - GuruFocus
Neuberger Berman Group LLC Has $30.29 Million Stock Position in Icon Plc $ICLR - MarketBeat
Quadrature Capital Ltd Has $5.14 Million Stock Position in Icon Plc $ICLR - MarketBeat
Boston Partners Sells 548,381 Shares of Icon Plc $ICLR - MarketBeat
Finanzdaten der Icon Plc-Aktie (ICLR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.15%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):